| EQA 2027 - Catecholamines and plasma metabolites (CATE) |
|---|
|
Expert Biologists - Program Coordinators:
Estelle BUGNI and Laetitia SELMAN EQA performed since 2017
Number of analytical sites registered in 2026: 32 |
| Program organised by ProBioQual and placed under the aegis of the FAEEQ |
|
1 – Program overview
This external quality assessment program evaluates the accuracy of catecholamines, methoxylated derivatives, serotonin and 5-hydroxyindoleacetic acid assays in blood.
Participating labs can choose to be assessed for all the analytes of this program, or simply a subset of analytes of interest.
2 – Assessment frequency
Number of surveys per year: 4
Number of control samples per survey: 1 or 2
Number of samples per year: 6
CAUTION: one sample is used to assess 5-hydroxyindoleacetic acid (5-HIAA), serotonin and the catecholamines (adrenaline, noradrenaline and dopamine); another is used to assess the methoxylated derivatives (metanephrine, normetanephrine and 3-methoxytyramine).
3 – List of analytes assessed
4 – Description of the control samples
Lyophilised human control plasma and serum (samples to be resuspended in 3 or 5 mL of distilled water).
| | Legal notices and privacy policy | General terms of sale | | Last updated: 13 October 2026 | Copyright © 2011-2026 ProBioQual All rights reserved |